{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:34:47Z","timestamp":1762540487035},"reference-count":32,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.schres.2012.02.031","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T14:33:53Z","timestamp":1334673233000},"page":"164-170","source":"Crossref","is-referenced-by-count":18,"title":["Antipsychotic drug effects on left prefrontal phospholipid metabolism: A follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients"],"prefix":"10.1016","volume":"138","author":[{"given":"Stefan","family":"Smesny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Langbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhardt","family":"Rzanny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gussew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut P.","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen R.","family":"Reichenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.schres.2012.02.031_bb0005","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bbamem.2011.02.021","article-title":"The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods","volume":"1808","author":"Alves","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.schres.2012.02.031_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1440-1614.2001.01021.x","article-title":"Implications of lipid biology for the pathogenesis of schizophrenia","volume":"36","author":"Berger","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-977X(02)00003-2","article-title":"Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia","volume":"12","author":"Braus","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2012.02.031_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-4927(01)00102-0","article-title":"Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia","volume":"107","author":"Bustillo","year":"2001","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.schres.2012.02.031_bb0025","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/sj.npp.1301631","article-title":"Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia","volume":"33","author":"Bustillo","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pscychresns.2009.04.007","article-title":"The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response","volume":"174","author":"Ertugrul","year":"2009","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/15622970109027496","article-title":"Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy","volume":"2","author":"Fukuzako","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2012.02.031_bb0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0893-133X(99)00050-0","article-title":"Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients","volume":"21","author":"Fukuzako","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.schres.2012.02.031_bb0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1176\/appi.ajp.161.7.1304","article-title":"Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study","volume":"161","author":"Gangadhar","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2012.02.031_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cercor\/bhg107","article-title":"Neuroanatomy of \u201chearing voices\u201d: a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia","volume":"14","author":"Gaser","year":"2004","journal-title":"Cereb. Cortex"},{"issue":"9","key":"10.1016\/j.schres.2012.02.031_bb0055","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2012.02.031_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-3223(01)01321-X","article-title":"Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine","volume":"51","author":"Goff","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"416","key":"10.1016\/j.schres.2012.02.031_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"4","key":"10.1016\/j.schres.2012.02.031_bb0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0006-3223(02)01829-2","article-title":"Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study","volume":"54","author":"Jayakumar","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.02.031_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1192\/bjp.184.5.409","article-title":"Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla","volume":"184","author":"Jensen","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2012.02.031_bb0080","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2012.02.031_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00213-005-2199-1","article-title":"N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives","volume":"179","author":"Millan","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12154-009-0018-6","article-title":"In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner","volume":"2","author":"Oruch","year":"2009","journal-title":"J. Chem. Biol."},{"key":"10.1016\/j.schres.2012.02.031_bb0100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.yco.0000214339.06507.d8","article-title":"Effects of antipsychotics on brain structure","volume":"19","author":"Scherk","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.02.031_bb0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuroimage.2006.12.023","article-title":"Metabolic mapping using 2D (31)P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia","volume":"35","author":"Smesny","year":"2007","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.schres.2012.02.031_bb0110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/15622975.2010.541283","article-title":"Phospholipase A activity in first episode schizophrenia: associations with symptom severity and outcome at week 12","volume":"12","author":"Smesny","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2012.02.031_bb0115","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuroimage.2010.05.009","article-title":"Phospholipase A2 activity is associated with structural brain changes in schizophrenia","volume":"52","author":"Smesny","year":"2011","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.schres.2012.02.031_bb0125","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0006-3223(00)00949-5","article-title":"Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings\u2013part I","volume":"48","author":"Stanley","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2012.02.031_bb0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2005-873156","article-title":"The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS)","volume":"38","author":"Szulc","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2012.02.031_bb0135","first-page":"17","article-title":"N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study","volume":"13","author":"Szulc","year":"2007","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.schres.2012.02.031_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2009.11.011","article-title":"GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study","volume":"117","author":"Tayoshi","year":"2010","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2012.02.031_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pscychresns.2004.08.001","article-title":"Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla","volume":"132","author":"Theberge","year":"2004","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.schres.2012.02.031_bb0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0006-3223(98)00061-4","article-title":"31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics\u2013a study including 50 patients and 36 controls","volume":"44","author":"Volz","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2012.02.031_bb0155","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0006-3223(00)00235-3","article-title":"Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study","volume":"47","author":"Volz","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.02.031_bb0160","series-title":"Structured Clinical Interview for DSM-IV","author":"Wittchen","year":"1997"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T02:50:59Z","timestamp":1543027859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996412001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":32,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0920996412001533"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.02.031","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}